Shanghai OPM Biosciences Co., Ltd. (SHA:688293)
56.95
+0.47 (0.83%)
At close: Jan 22, 2026
Shanghai OPM Biosciences Company Description
Shanghai OPM Biosciences Co., Ltd. provides cell culture media and CDMO services in China and internationally.
The company offers cell culture media and feed supplements, such as OPM's CHO-Platform, OPM-293 Platform, and VegaCHO media and feeds, as well as customized cell culture media development services.
It also provides end-to-end biologics CDMO services, such as antibody discovery, stable cell line development, cell banking, upstream process development, downstream process development, formulation development, and quality control and product characterization of biologics.
The company was founded in 2013 and is headquartered in Shanghai, China.
Shanghai OPM Biosciences Co., Ltd.
| Country | China |
| Founded | 2013 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 328 |
| CEO | Zhihua Xiao |
Contact Details
Address: Building 28 Shanghai, 201321 China | |
| Phone | 86 21 2078 0178 |
| Website | opmbio.com |
Stock Details
| Ticker Symbol | 688293 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Zhihua Xiao | Chairman and GM |
| Liangping Ni | Chief Financial Officer, Accounting Supervisor, Deputy GM and Director |
| Yun Fen He | Deputy GM and Director |
| Xiaohan Ma | Secretary to the Board |